Purchase Order 75N91023P00246
- Not listed
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute (NCI) awarded a $388,749.60 firm fixed-price purchase order to Sony Biotechnology Inc. for a Sony MA900 cell sorter. The cell sorter is critical to support the NCI's research mission, particularly for the Laboratory of Tumor Immunology and Biology's efforts to develop novel immunotherapies for cancer treatment. The contract includes preventive maintenance, emergency repair services, software...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,750 purchase order to Sony Biotechnology Inc. for a service agreement for Sony MA900 cell sorters. The place of performance will be in Rockville, Maryland. The period of performance is one year, from July 1, 2023 through June 30, 2024. The contract pricing is firm fixed price. No additional details were provided regarding subcontractors or the National Cancer Institute's programs....
- This firm-fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Sony Biotechnology Inc. The $192,019.16 contract is for maintenance services on a Sony multi-function cell sorter utilized by the NCI's Center for Cancer Research, Oncology Surgery Branch. The contract has a base period ending on July 18, 2026 and does not have a set-aside...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $353,798 firm-fixed-price purchase order to Sony Biotechnology Inc. to procure one Sony MA900 cell sorter or equivalent in support of lymphoid malignancies research. The cell sorter will be delivered within 30 days of award to the National Institutes of Health campus in Bethesda, Maryland, installed within 14 days thereafter, and include two days of training within 30 days of...
- The National Cancer Institute (NCI) awarded a $40.8K firm fixed-price purchase order to Sony Biotechnology Inc. for maintenance services on the Sony ID7000 Spectral Flow Cytometer. The contract, which carries no set-aside designation, is scheduled for completion by March 1, 2027, and will be performed at the NCI facility in Bethesda, Maryland. Sony Biotechnology Inc., based in San Jose, California, is a specialized manufacturer of advanced flow cytometry and imaging instrumentation that has...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH), National Cancer Institute (NCI), to Sony Biotechnology Inc. for preventative and emergency maintenance services on one government-owned Sony Biotechnology, Inc. SH800S cell sorter. The equipment is critical to ongoing cancer research at the NCI's Center for Cancer Research (CCR) Surgery Branch. The $155,978.10 contract does not utilize a set-aside, and provides...
- This firm-fixed-price purchase order contract was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sony Biotechnology Inc. for preventive maintenance services on one (1) Sony LE-SA800 cell sorter. The contract has a ceiling value of $119,475.00 and a completion date of April 12, 2028. Sony Biotechnology Inc. is a specialized manufacturer and provider of flow cytometry and imaging instrumentation, reagents, and services to...
- This is a $141,780.00 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Sony Biotechnology Inc. for a one-year system maintenance service agreement on a Sony MA900 multi-application cell sorter. The contract has four one-year option periods, for a total potential period of performance through September 10, 2025. The contract was awarded on a sole-source basis, as Sony is the only provider capable of...
- This is a $152,280.00 firm-fixed-price purchase order contract awarded by the National Cancer Institute, a component of the National Institutes of Health under the Department of Health and Human Services, to Sony Biotechnology Inc. for preventive maintenance services on a single Sony MA900 cell sorter. The contract has a period of performance through June 30, 2029. Sony Biotechnology is a for-profit manufacturer that provides flow cytometry and imaging instrumentation, reagents, and services...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute awarded Sony Biotechnology Inc. a $294,798.40 firm-fixed-price purchase order contract for the acquisition of a Sony SH800 fluorescence-activated cell sorter. The contract was not set aside for any specific business type. Sony Biotechnology Inc. is a for-profit manufacturer of flow cytometry and imaging instrumentation, reagents, and services to support biomedical research. The...
The National Cancer Institute awarded a firm fixed-price purchase order to Sony Biotechnology Inc. for maintenance services on two government-owned Sony MA900 cell sorters supporting the NCI's Center for Cancer Research Vaccine Branch and Pediatric Oncology Branch. This contract covers option periods 2 and 3, with a combined ceiling value of $335,016 and an ultimate completion date of February 29, 2028. The work will be performed in Potomac, Maryland, and no small business set-aside was utilized for this procurement. Sony Biotechnology Inc., a specialized manufacturer of advanced flow cytometry and cell sorting instrumentation based in San Jose, California, has an extensive history of providing scientific equipment and maintenance services to the National Institutes of Health and its constituent institutes. The MA900 cell sorters are critical instruments for the NCI's cancer research programs, enabling researchers to isolate and analyze specific cell populations. As a parent organization with significant federal contracting experience primarily within the Department of Health and Human Services, Sony Biotechnology is well-positioned to maintain optimal performance of these sophisticated research instruments essential to the NCI's vaccine development and pediatric oncology research initiatives.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
AWARD NOTICE: Maintenance Service for two (2) SONY MA900 Cell Sorters | 75N91023P00246 | Department of Health and Human Services National Institutes of Health National Cancer Institute | Award Notice 1/1 | 3/1/23, 12:00 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $67.0k | 2/23/26 | |
| P00002 | Exercise an Option | $67.0k | 2/28/25 | |
| P00001 | Exercise an Option | $67.0k | 2/9/24 | |
| Not listed | Not listed | $67.0k | 2/16/23 |